Transcript Increaseing Access to and Delivery of HPV Vaccines

HPV VACCINATION
Dr Frida Mghamba
2nd East Africa WE CAN
Summit
11th September 2014
Outline
• Introduction
• Comprehensive approach for cervical cancer
prevention and control
• HPV vaccination Demonstration project
• Lesson learned in HPV vaccination
• Role of GAVI and WHO
Introduction
• Cervical cancer is the abnormal uncontrolled
growth of cells in the cervix.
• The cells of the cervix change in a way that
leads to abnormal growth and invasion of other
tissues or organs of the body.
•
Nearly all cervical cancers are caused by HPV
infection.
• There are more than 40 HPV types that can
infect the genital areas of males and females
• The HPV types 16 and 18 account for about
70% of all HPV cervical cancers worldwide
Comprehensive Approach to cervical
cancer prevention and control
• Primary prevention
– Education: delay age of first sexual
intercourse, use condoms, limit number of
partners, avoid tobacco use
– HPV vaccines
• Secondary prevention: early
detection
– Screening: Identify and treat precancerous
lesions before they progress to cervical
cancer
– Early diagnosis: Identify and treat early
cancer while chance of cure is still good
(reduces cervical cancer mortality)
• Tertiary prevention: treatment and
palliative care
HPV vaccination
• HPV vaccination is the primary preventive method for
cervical cancers caused by HPV infection.
• It prevents women from acquiring HPV infection in the
first instance, so there is no risk of an infection
progressing to cervical cancer later in life.
• The vaccine is recommended by WHO for ages 9-13
years.
• The HPV vaccine is safe , very effective and provides
complete immunity after two doses six months apart.
•
HPV vaccination demonstration
project
• HPV demonstration project aims to demonstrate how the HPV
vaccine targeting girls aged 9-13 years can be delivered in routine
setting and its implication on coverage feasibility, acceptability and
cost.
•
Target age group for the HPV vaccination is school-going girls,
school-based vaccination is one of the vaccination strategies
adopted to achieve the best coverage rates.
• Data from the MOEVT show that girls with 9-13 years 95% are in
grade IV therefore this programme target all girls in class IV with
age 9 and above.
• The girls out of school due to various reasons was vaccinated with
age of 9years..
RESULT OF HPV VACCINATION
• 1st round of HPV vaccination was conducted
on 5th to 9th May this year in Kilimanjaro
region
• Total number of girls vaccinated in school was
17,222 out of 18,316 (94.0%)
• The girls vaccinated out of schools were 416
out of 597(69.70%).
• Overall coverage was 93%
HPV VACCINATION COVERAGE
CHALLENGES
• Misconception among
parents/guardian
• Refusal because of
religious belief in three
religious schools
• Fund for operational for the
2nd year
LESSON LEARNT
• Community health worker can be used as platform for reaching hard
to reach and out of school
• Through micro planning resulted into good vaccination coverage,
better resources utilization and avoidance of duplication
• Operational plan correctly resulted into appropriate proper
distribution of vaccine and supplies
• Delivering of vaccine in school is cheap and cost effective strategies
• Targeted girls who were already vaccinated can be used as
ingredient for change and increase acceptance among girls and
community
ROLE OF GAVI AND WHO
GAVI
• To provide financial support
• To supply HPV vaccines
WHO
• To provide technique support in
– Training
– Supportive supervision
– Monitoring and evaluation
Thank you